SEQUENOM INC SQNM (NASDAQ) $ 16.09 Change: +0.16 +0.99% | Volume: 3,465,044
Sponsored by Click here!

SEQUENOM INC - Fundamental Profile

Company Information

Ticker Symbol: SQNM
Exchange: NASD
Contact Info: 3595 John Hopkins Court San Diego CA 92121 858 202-9000
CEO/President: Harry Stylli Ph.D.
Industry: Medical - Biomedical / Standard Industry Code: 8731
Description: Sequenom Inc. is in the field of industrial genomics. Industrial genomics is the large scale commercial use of the knowledge of DNA variations for improving health, agriculture and livestock. These variations are the differences between individuals, including disease predispositions and variations in drug responses. Single nucleotide polymorphisms are the most common variations. The company has developed the MassArray system, an accurate, cost-effective technology that is capable of high throughput single nucleotide polymorphism analysis at high speeds.

Share Information

Shares Outstanding: 50,260 (000) Market Value: 904,740 ($000)
Percentage of Inst.Shareholders: 70.18% Number of Inst.Shareholders: 3.60%
Last Quarter Sales: 12.85 ($Mil.) Last Quarter Net Income: -9.74 ($Mil.)
Last Quarter EPS: -0.21 P/E Ratio: 0
Most Recent Earnings: -0.21 on 07/30/08 Earnings Per Share: -0.70
Most Recent Split: 1-3 on 06/02/06 Annual Dividend Rate: 0
Most Recent Dividend: Annual Dividend Yield: 0%
Data Provided By Barchart.com
CoreData does not represent, warrant, or guarantee completeness, accuracy or timeliness of its data, and shall have no liability of any kind whatsoever to any party on account of any incompleteness of, inaccuracies in or untimeliness of the CoreData content provided hereunder, or for any delay in reporting such data. CoreData expressly disclaims all warranties of fitness of the CoreData content or computations and analyses thereof for a particular purpose or use.
advertisement

Top Competitors

AMGEN -15.10 48.58
GILEAD SCIENCES -26.60 37.47
GENENTECH INC -9.90 73.00
CELGENE CP -26.70 54.52
BIOGEN IDEC INC -34.90 42.78